# J2 Ventures **J2 Ventures** (J2VP) is a Boston-based, early-stage venture capital firm co-founded by [[Alex Harstrick]] and Jonathan Bronson that helped popularize the "dual-use" investment category — backing companies whose technology serves both commercial markets and U.S. national security. The firm pitches itself as national-security *adjacent* rather than weapons-focused: it explicitly does not invest in drones, robotics, or surveillance, and frames its mission around the health, safety, and wellbeing of the ~3 million people the U.S. military employs. Its four declared focus sectors are advanced computing, biomedical engineering, cybersecurity, and infrastructure. ## Funds J2 has raised three funds in four years, each named for a U.S. national laboratory: - **Inaugural fund** — ~$68M (2021) - **Argonne Fund** — $150M (2024), oriented toward military healthcare and dual-use deep tech - **Brookhaven Fund** — $250M, oversubscribed, closed November 2025 Disclosed limited partners include JP Morgan, MetLife, Upsher-Smith, Alpha Leonis Partners, and the State Investment Council of New Mexico — an establishment, institutional LP base (a state pension fund and large insurers) rather than a MAGA-aligned or ideological one. J2 reports that its portfolio companies raise an average of $2 in non-dilutive government funding for every $1 the firm invests, which is the core of its pitch to founders: it sells access to the federal procurement and grant pipeline as much as capital. ## Team The partnership leans heavily on a Defense Innovation Unit / uniformed-service pedigree: - **Alex Harstrick** — Managing Partner, Co-Founder (Army reservist, ex-[[Defense Innovation Unit]]); see [[Alex Harstrick]] - **Jonathan Bronson, PhD** — Managing Partner, Co-Founder - **Christine Keung** — Partner (former Chief Data Officer for the City of San Jose; former Small Business Administration appointee) - **Matthew Goldman** — Partner (retired Air Force colonel; former Chief Medical Officer of the Defense Innovation Unit) - **Adam Briley** — Director of Federal Solutions (retired Navy SEAL Master Chief; leads the firm's federal-programs practice) Its advisory bench reinforces the military-medical orientation — including **Patricia D. Horoho** (retired Army Lieutenant General and former Army Surgeon General), **Raquel Bono, MD** (retired Navy Vice Admiral), and Harvard Business School professor **Paul Gompers, PhD**. ## Portfolio J2 reports roughly 30–45 active investments depending on the source (it has backed 35+ startups across its funds). Three have reached unicorn status: **Code Metal** (edge AI/data science, became a unicorn in 2026), **Apex Space** (satellite-bus manufacturing), and **Oura** (the Oura Ring health wearable). The portfolio spans its four sectors: - **Advanced computing / AI:** Code Metal, Femtosense, Paravision, Phoenix Semiconductor, VectorWave, MesaQuantum, GameBeast, Holly, Flashpass Education - **Biomedical engineering:** Oura, Tasso (needle-free blood testing), Safi (bio-manufactured blood), Sealonix, Somnair, Micron Biomedical, Empress Therapeutics, Aether, Lumia Health, Parallel Fluidics - **Cybersecurity / trust & safety:** Unit 221B, Acalvio, Cinder, iCOUNTER, Kusari, Musubi, Nametag, Redcoat AI - **Infrastructure / space / critical minerals:** Aalyria (Alphabet spinout, laser space networking), Apex Space, SkyFi, Ravn, Druid, InfiniG, Plato Systems, LightSource, Arkenstone Defense, and Principal Mineral (U.S. [[Critical Minerals]] resilience) ## The a16z Co-Investment Map The clearest concrete tie between J2 and figures already covered on this site is its overlapping cap tables with **[[Andreessen Horowitz]]** ([[Marc Andreessen]]'s firm) and its [[American Dynamism]] defense practice. Deal-data aggregators describe a16z as sharing a "substantial percentage" of J2's portfolio, though most individual rounds aren't separately disclosed. The confirmed, documented shared deal is **Apex Space**: - a16z **led** Apex's $7.5M seed round out of stealth (October 2022), with **J2 Ventures** participating alongside Lux Capital, XYZ, and Village Global. - a16z **co-led** the 2023 Series A (with Shield Capital); J2 remained in. - Both a16z and J2 stayed in through the $95M Series B (June 2024, led by XYZ with CRV). So on at least one marquee American Dynamism company, J2 has ridden alongside a16z from seed through growth. By contrast, J2's other satellite-comms bet, **Aalyria**, was led by Battery Ventures and J2 (not a16z) in its $100M Series B (February 2026) — a useful reminder that the "substantial overlap" framing is real but should be deal-checked rather than assumed wholesale. Other co-investors recurring across J2 rounds include [[Lux Capital]], Shield Capital, XYZ Venture Capital, and 8VC ([[Joe Lonsdale]]'s firm; see [[8VC]]), placing J2 inside the broader defense-tech VC syndicate alongside [[Founders Fund]], [[Anduril]], and [[Palantir]] in the [[Military-Industrial Complex]] capital stack. ## RWKB Relevance J2 sits inside the militarized-Silicon-Valley / [[Defense Innovation Unit]] pipeline the vault tracks, and the DIU-alum-turned-defense-VC career arc (see [[Alex Harstrick]]) is itself a worth-tracking pattern: the government-to-private-defense-capital revolving door, staffed here by ex-DIU and senior retired officers. As of June 2026, no evidence of partisan/right-wing political alignment, Trump-world ties, or [[1789 Capital]]-style ideological positioning has surfaced. J2's LP base, advisor bench, and stated investment guardrails (no drones/surveillance) read as establishment/centrist national security. It should be treated as a **dual-use VC node, NOT a MAGA-aligned actor**, unless a real political tie or [[Office of Strategic Capital]]-style federal-contract conflict emerges among its portfolio companies. Flag for re-evaluation if either appears.